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Abstract
Recent literature shows a controversial new push to tie microorganisms to 
Alzheimer’s disease (AD). Study after study, in which scientists have injected human 
Alzheimer-diseased brain tissue into mice and other laboratory animals that later 
developed the disease have left little doubt that Alzheimer’s disease (AD) arises 
from an infectious process. By 2013 Mawanda and Wallace’s “Can Infections Cause 
Alzheimer’s Disease” struck down some of the commonly entertained pathogens 
for AD such as herpes simplex virus type 1, Chlamydia pneumoniae, and several 
types of spirochetes. Instead they pointed to two prime suspects for Alzheimer’s 
amyloid-beta deposition: “especially chronic infections like tuberculosis and 
leprosy.” To be sure, it was German neuropathologist Oskar Fischer of the Prague 
school of Neuropathology, Alzheimer’s great rival, who was the first to suggest that 
infection might be causative for Alzheimer’s. Fischer’s credentials: he was the co-
discoverer of Alzheimer’s disease. His suspected germ was the Streptothrix, today 
classified as Actinomycetes, a rare central nervous system pathogen which at the 
time was so constantly and consistently mistaken for tuberculosis that Choppen-
Jones suggested that TB be called tuberculomycosis. And Just ten years before 
Oskar Fischer found Actinomycosis-like forms in Alzheimer’s cerebral plaque, 
Babèş and immunologist Levaditi reported in “On the Actinomycotic Shape of the 
Tuberculous Bacilli” that Fischer’s typical Actinomyces-like clusters (Drüsen) with 
clubs appeared in the tissue of rabbits inoculated with tubercle bacilli beneath 
the dura mater of their brains. Investigators who supported and subsequenly 
followed up on Fischer’s Alzheimer’s germ are also discussed.
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Introduction
By February 9th, 2016 the Journal of Alzheimer’s disease (JAD) 
accepted an informative Editorial entitled “Microbes and 
Alzheimer’s Disease” by Neurobiologist Ruth Itzhaki and others, 
signed-off on by 31 scientists from around the world [1]. Much 
of that Editorial rehashed subject matter already addressed by 
Mawanda and Wallace in “Can Infections Cause Alzheimer’s 
Disease”, just three years (2013) before [2]. 
Itzhaki also appeared in a 1997 piece for Lancet, regarding Herpes 
simplex virus type 1 in conjunction with APOE-epsilon 4 allele as 
a strong risk factor for AD, though either of these features alone, 
she mentioned up front, do not increase the risk of AD [3]. People 
who have symptoms of late onset Alzheimer disease (AD) and 
have one or more APOE e4 copies are more likely to have AD. 
However, this is not diagnostic of AD, nor should it be used to 
screen asymptomatic people or their family members. Many of 
those who have e4 alleles will never develop AD. And even in 
symptomatic people, only about 60% of those with late onset AD 
will have APOE e4 alleles [4,5]. 
The topic of Alzheimer’s as of infectious disease origins has been 
accepted by many, but some of the specific infectious agents 
mentioned by Itzhaki et al. as possibly being responsible for 
Alzheimer’s disease are open to question. Specifically, Itzhaki 
has implicated the following agents found in the elderly brain as 
possibly causative to Alzheimer’s: (1) herpes simplex virus type 
1 (HSV-I), (2) Chlamydia pneumoniae, and (3) several types of 
spirochetes. Also mentioned were (4) fungal infection in the AD 
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brain as well as (5) abnormal microbiota (commensal, symbiotic 
and pathogenic microorganisms that literally share our body 
space) which have already been found in the blood of Alzheimer’s 
patients [1]. 
On the other hand, Mawanda and Wallace’s review (2013) had 
already given seven annotated references as to why HSV–1 
“remains questionable” as a cause for Alzheimer’s; nine studies 
referencing as to why there was “no evidence to suggest an 
association between Chlamydia pneumoniae infection and 
AD pathogenesis”; and six “rigorous studies which found no 
evidence to suggest that spirochetal B. Burgdorferi, is “causally 
linked to AD.”[2] Wallace also mentioned that although Riviere 
et al. found oral spirochetal Treponema, including T. denticola, 
T. pectinovorum, T. vincentii, T. amylovorum, T. maltophilum, T. 
medium, and T. socranskii in a significantly higher proportion of 
postmortem brain specimens from AD cases than controls, [6] that 
these results have, however, not been replicated. Furthermore, 
Oskar Fischer, the discoverer of Alzheimer’s plaque, failed to 
observe it in the brains of 45 cases with neurosyphilis [7]. In 
fact even Alzheimer himself and E.E. Southard of Harvard, both 
experts on the detection of neurosyphilis –never implied that 
syphilis was even nearly behind the bulk of Alzheimer’s cases. 
And while one out of the four cases that Alzheimer turned over 
to his colleague Perusini had neurosyphilis, that case also had a 
lung scarred by a previous encounter with tuberculosis.
What Mawanda and Wallace did maintain, however, was the 
emerging evidence that supported an infectious pathogen and 
two prime suspects for Amyloid beta deposition to the extent 
that it was going on in Alzheimer’s. They said this: 
“In addition, amyloidopathy–a condition characterized by 
elevated levels of serum amyloid and by amyloid deposition and 
aggregation in tissues–is a frequent occurrence in several acute 
and chronic systemic inflammatory conditions, especially chronic 
infections like tuberculosis and leprosy.” IBID( 2) p.162
And there seemed to be no dearth of studies referenced to 
substantiate that statement [8-14]. 
As for Aloise Alzheimer himself, he was already too bogged down 
by his boss Emil Kraepelin’s edict that Alzheimer’s disease be 
a new disease to get involved in specifically what caused it. So 
instead Alzheimer would continue to speak about and probe the 
gross pathology of what he had found in Alzheimer’s disease:
“Very remarkable and really without precedent in the pathological 
anatomy of the nervous system are the alterations of (brain 
neuron) axis–cylinders (the central core of the axon of in this case 
brain neurons), so exhaustively described by Fischer.”[15]
But, in reality nothing Alzheimer mentioned was without 
“precedent.” True, Fischer, Alzheimer’s great European rival, was 
credited with establishing senile dementia, which Fischer felt 
was part and parcel of Alzheimer’s disease –and he exhaustively 
worked on the alterations to axon cores in Alzheimer’s. Yet 
Barlow, [16] in describing neurotuberculosis seven years prior 
to Alzheimer and Fischer’s work, mentioned both Fischer’s 
degenerative plaque alterations in the brain’s neuronal axis–
cylinders and Alzheimer’s own observation with regard to the 
fibrillary degenerative tangles of cerebral ganglion cells under 
tuberculous attack. Here is Barlow’s explanation for such 
tubercular “plaques” and “tangles”:
Microscopic investigations throws some light upon this condition 
(cerebral tuberculosis): The deposition of miliary tubercle in the 
subarachnoid, and along the ingrowing processes of pia mater, 
not only interferes with the vascular nutrition of the brain 
substance, but actually invades it, giving rise to extensive cellular 
infiltration, and causing degeneration of both axis–cylinders 
(of brain neurons) and ganglion cells. This seems to justify 
the modern designation of the disease as a true (tubercular) 
meningoencephalitis [16].
Also, it is improbable that Alois Alzheimer did not read and 
absorb the parallels between Otto Ranke’s work on central 
nervous system tuberculosis and his own histological findings 
on Auguste Deter’s brain [17]. Alzheimer and his lifetime friend, 
Franz Nissl, began to jointly edit the journal Histologische 
und histopathologische Arbeiten uber die Grosshirnrinde–a 
publication Ranke’s TB meningitis review was accepted into and 
then published in 1908. 
Despite such knowledge of possible linkage between cerebral 
tuberculosis and Alzheimer’s disease–an association implied 
not only by Alzheimer’s German and European colleagues but 
subsequently by Southard at Harvard and Clouston at Edinburgh 
–and despite the seven million deaths per year from a tubercular 
disease that led to TB sanatoria sprouting up like weeds all 
around him– Alzheimer’s silence was singular (Figures 1 and 2). 
Alzheimer doubled down on his carefully manicured hypothesis, 
repeatedly beseeching neurologists and psychiatrists alike 
not to look toward “well–known disease” as being behind this 
“new disease.” After all, it had to be a “new” disease because 
Alzheimer’s chief, Emil Kraepelin, demanded that it be new.
Department of Neuropsychiatry, the 
German University of Prague, Prague, 
Czechoslovakia, 1907
It thus becomes a matter of great curiosity and interest that 
from the beginning, Alois Alzheimer’s main rival, German 
neuropathologist Oskar Fischer, thought he had spotted, 
throughout his Alzheimer’s brain autopsies, a tubercular–like 
germ called Streptothrix, often confused with the filamentous 
forms of the tubercular bacilli (Figure 3). For Fischer, this was the 
possible infectious cause of Alzheimer’s.
Fischer’s findings were never meant to be taken lightly. Historical 
circumstance mandates that we owe as much to Oskar Fischer 
for the discovery of Alzheimer's disease as to Alois Alzheimer 
himself. Doubters have to go no further than Alzheimer's 1911 
paper, which is in part a running dialogue between Alzheimer’s 
own feelings and findings and those of the Prague Institute of 
Neurology’s Dr. Oskar Fischer [18]. Indeed, the only reason why 
what we call “Alzheimer’s disease today is not called “Alzheimer–
Fischer’s disease” or just “Fischer’s disease” has simply to do 
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 Some of the other fortress-like TB sanatoria dotting Germany circa Alzheimer’s time. (From F. R. Walters, Sanatoria for 
Consumptives, Swan Sonnenschein & Company, Ltd., London, 1899).
Figure 1
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Alzheimer's great rival, Oskar Fischer (1876–1942), around 
the time of his sixtieth birthday in 1936.
Figure 3
A more comprehensive list of the burgeoning, ever-growing German TB treatment sanatoria operative throughout unified Germany 
during Dr. Alzheimer’s career (From F. R. Walters, Sanatoria for Consumptives, Swan Sonnenschein & Company, Ltd., London, 1899).
Figure 2
with the course of world history, the rise of Nazi Germany, and 
Alzheimer’s boss, Emil Kraepelin, high priest of early German 
psychiatry.
A Prague neuropathologist of German–Jewish origin, for years 
Oskar Fischer’s presbyophrenia –a form of senile dementia 
characterized by marked memory loss - and Alzheimer’s disease, 
supposedly a “presenile” dementia, were used interchangeably. 
And in a 1916 review, Spielmeyer, who would eventually replace 
Alzheimer at Munich, revealed that even Alzheimer himself 
knew that the presenile decline he had “discovered” in people 
in their late forties, fifties, and early sixties was nothing really 
new [19]. It was simply what Fischer had already characterized 
with somewhat of an earlier age of onset, at a time when certain 
pathologic findings were more prominent.
It has also become more and more obvious that just as Oskar 
Fischer implicated to begin with, there is an association between 
dementias such as Alzheimer’s and infectious disease [20,21]. 
Often, Alzheimer’s plaque looks like colonies of bacteria, which 
would account for the disease’s chronic inflammation that 
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years. Most people who have Alzheimer’s disease die within eight 
years of their diagnosis–typically from infection or “pneumonia,” 
not cognitive failure.
Victor Babes might have been among the first bacteriologists, 
but he also had a sharp interest in the nervous system. Later he, 
Blocq, and Marinescu would publish An Atlas of the Pathologic 
Histology of the Nervous System [28]. Neither Blocq, Marinescu, 
nor Oskar Fischer were bacteriologists, but Victor Babes was. 
Born in Vienna, Babes at one point worked with Robert Koch in 
Berlin but split with him over Koch’s insistence that the only form 
real tuberculosis could take was its bacillary form. Babes, who 
also worked with Pasteur, knew better (Figure 5). 
Yet subsequently, bacteriologists Vera and Rettger of Yale openly 
contradicted Koch [29]. Vera wrote, “The single point on which 
all investigators have agreed is that the Koch (tubercular) bacillus 
damages brain neurons. But what has recently brought this 
microbial hypothesis into sharper focus than ever have been 
microscopic findings that microbes such as tuberculosis, a disease 
historically associated with human amyloidosis to begin with, can 
produce amyloid fibrils identical to those found in Alzheimer’s 
plaque [22]. Moreover, such bacteria–manufactured amyloid 
fibrils elicit the same response from the brain’s immune cells as 
does Alzheimer’s amyloid plaque, the sticky buildup of proteins 
that accumulates outside of Alzheimer’s nerve cells [23]. Kidd 
confirmed as early as 1963 that the amyloid of Alzheimer’s was 
indistinguishable from amyloid generated by an infection such 
as TB [24].
But to be sure, Oskar Fischer was the first on record to suggest 
that infection might be causative for either Alzheimer’s presenile 
dementia or his own senile dementia [25]. Fischer’s infectious 
view never gained immediate popularity, although today, more 
than a century later, a volume of data supporting such an approach 
has begun to accumulate. But was Fischer’s specific microbe on 
the right track to discovering the cause of Alzheimer’s to begin 
with? Documents uncovered since then seem to suggest that he 
was considerably closer than anyone else –either then or since.
As a member of the Prague School of Neuropathology, headed by 
famed neuropathologist Arnold Pick, Oskar Fischer’s credentials 
were flawless. At the time, the Prague school was one of two 
neuropathological schools in Europe. The other was in Munich, 
headed by Emil Kraepelin, where Alzheimer worked. Fischer’s 
detailed drawings showed neuritic Alzheimer brain plaque with 
abnormal, club–shaped neurons (Figure 4) and small branching 
complexes leading to the displacement of the rest of the normal-
looking nerve fibrils in the space occupied by the plaques. These 
where the “drüsen,” occasionally club–shaped, that Fischer 
repeatedly wrote about.
At the time, it was widely acknowledged that such drüsen could 
result from either infection with Streptothrix, now known as 
Actinomycosis (aktinomycesdruse), a rare disease in humans, 
or tuberculosis, a disease that by 1882, as Alzheimer prepared 
to leave for Berlin for his medical education, was understood to 
be far and away the leading cause of infectious death in Europe. 
During Alzheimer’s and Fischer’s lifetimes, tuberculosis’s annual 
death rate of seven million persons per year was more than twice 
the approximately two to three million people some estimate it 
still kills annually [22]. Furthermore, clinically there has always 
been a subset in adults with cerebral tuberculosis whose clinical 
features included a slowly progressive dementia over months 
or years characterized by, among other things, memory deficits 
[26].
Tubercular cerebral plaque, one subset of which is called 
tuberculoma en plaque, was first described by French authors, 
notably Chantemesse in 1884, eight years before Blocq and 
Marinescu stumbled across their “senile” plaque [27].
Chantemesse’s cerebral plaque was a chronic, proliferating, 
fibroid type of tuberculosis, with extensive areas involving the 
meninges of the brain’s cortex. The average survival with such 
tubercular plaque–ridden brain disease was approximately seven 
The thick, black, club-shaped "Drüsen" in Oskar Fischer's 
1907 drawing of senile plaque. [From Fischer O. Miliare 
Nekrosen Mit Drusigen Wucherungen der Neurofibrillen, 
eine Regelmassige Veranderung der Hirnrinde bei Seniler 
Demenz [Miliary Necrosis with Nodular Proliferation 
of the Neurofibrils: A Common Change of the Cerebral 
Cortex in Senile Dementia). Monatsschr f Psychiat Neurol 
1907; 22: 361-372.]
Figure 4
Physician and early bacteriologist Victor Babes (1854–1926).Figure 5
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does not always manifest itself in the classical rod shape. While 
at times and most commonly the organism appears as a granular 
rod, coccoid bodies, filaments, and clubs are not rare [29].” 
And so, just ten years before Oskar Fischer found Actinomycosis-
like forms in Alzheimer’s cerebral plaque, Babèş and 
immunologist Levaditi reported in “On the Actinomycotic Shape 
of the Tuberculous Bacilli” that typical Actinomyces–like clusters 
(Drüsen) with clubs appeared in the tissue of rabbits inoculated 
with tubercle bacilli beneath the dura mater of their brains 
[30]. Once introduced into the brain this way, reported Babes, 
TB bacilli not only branched out like the Actinomycosis such as 
Streptothrix, but they developed rosettes that were identical to 
the "drüsen" that Oskar Fischer spotted in Alzheimer’s plaque.
Neurology Clinic, Salpêtrière Hospital, 
Paris, France, 1892
After Gheorghe Marinescu had worked for eminent bacteriologist 
Victor Babèş for several years, Babes arranged a valuable 
government scholarship that enabled Marinescu to study under 
Jean–Martin Charcot in Paris. There, Marinescu met Paul Blocq.
By 1892, Blocq and Marinescu described, for the first time, senile 
plaques as perhaps microglial nodules in the cerebral gray matter 
of nine deceased epileptic patients with histories of seizures [31]. 
Blocq and Marinescu did not relate such plaque to dementia, as 
Oskar Fischer did. Nor did Blocq and Marinescu stipulate what 
specifically might have caused such plaque, other than possibly 
brain microglia. 
Nevertheless, Blocq and Marinescu were first to describe, upon 
histological examination of epileptic brains, such “small nodules” 
that were later named “senile plaque.” Marinescu describes 
what he found:
“Scattered throughout the various layers of the (brain’s) cortex, 
small round clusters with a diameter of about 60μm, distinguished 
from the rest of the tissue by a much more intense staining, and 
regular contours. They thus appear as vaguely dotted structures 
sprinkling the background of the slices. This is why it is possible 
to consider some of them at least as true multiple glial nodules. 
(?)”[31].
Microglia or “glia” are valuable elements in the brain’s immune 
system. The fact is that the central nervous system (CNS) can be 
invaded and damaged by a variety of microorganisms. Indeed, the 
body’s defense against such infections involves resident cells of 
the CNS, particularly microglia. However, it is only when microglia 
are activated by infection or inflammation that they produce 
“factors” that are detrimental and destructive to brain neurons 
in a culture, creating, among other things, cerebral plaque [32]. 
Microglia therefore are not in themselves the underlying cause 
of Alzheimer’s plaque. More probably, an infection capable of 
entering them intracellularly and altering their architecture and 
metabolism is.
A distinctive characteristic of infection with M. tuberculosis, a 
disease that according to WHO (the World Health Organization) 
affects a third of the world, is its capacity to enter and replicate 
within macrophages in the blood. Within the brain, microglial 
cells are the resident macrophages. As such, human microglial 
cells are productively infected with M. tuberculosis and are, in 
fact, its principal target in the CNS Figure 6 [33-35].
And just as the microglia are TB’s principal target in the brain, 
microglia themselves are central to the brain’s response to fight 
cerebral TB [36]. Once infected, microglia can then serve as a 
reservoir of tuberculosis, surviving and possibly creating a pool 
or source of infection for further tubercular attack in the brain. 
For all of these reasons, microglia have emerged as being key to 
understanding the neuropathogenesis of tuberculosis in the CNS. 
When TB attacks and infects the microglia in the brain, unlike most 
pathogens, it at first resides quite comfortably in the microglia’s 
cytoplasm within round, fluid–filled vacuoles, surviving and 
multiplying. Thus, TB and fowl–TB (avian tuberculosis) create 
their own cerebral infectious reservoirs. A short time later in 
such tubercular infection of the microglia, there is a retraction 
of the microglial processes. Tuberculosis will now direct a frontal 
offensive toward the brain’s immune system, its virulent strains 
looking to inhibit the very defensive microglial cytokines that are 
so deadly to most other microbes [37].
By 1910, Fischer, using staining techniques more advanced 
than either Redlich’s or Blocq and Marinescu’s, was able to 
demonstrate that senile plaques were not proliferating glial cells 
but rather a particular type of deposit of independent nature 
that subsequently “has been shown to have an outer area of 
degenerated neurons, a middle zone of swollen axons and 
dendrites, and a central amyloid core.”[38]
Blocq and Marinesco might never have connected the dots 
regarding why microglia might spawn senile plaque beyond 
their changed microglial architecture. But Marinesco’s haunting 
drawing, detailing the anatomical study of senile plaque, 
uncannily resembles the microbial attack (with drüsen) laid out 
for Alzheimer’s by Oskar Fischer Figure 7 [39].
Nervenklinik, Department of Clinical 
Psychiatry, University of Munich, 
Munich, Germany, 1907
In the form of Oskar Fischer, Alois Alzheimer and Emil Kraepelin 
soon realized that they had a huge problem Figure 8. Alzheimer 
acknowledged the importance of Fischer’s plaques in Alzheimer’s 
disease. Nevertheless, Alzheimer had to try to make his case 
that his findings were somehow different from Fischer’s. And 
to do so unfortunately would, in part, require raising some 
doubt regarding Fischer’s thoughts and findings. Thus, by 1911 
Alzheimer wrote the following:
“Hitherto opinions about the nature of the plaques have been very 
divergent. Fischer pointed out their similarity to bacterial colonies 
and reported that he had undertaken cultivation experiments and 
complement-fixation tests which however produced negative 
results” [18]. 
At the time Fischer undertook cultivation and compliment fixation 
tests to validate his germ, negative results were the rule, not the 
exception. Alzheimer should have known this. Thus, the fact that 
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attempts at running complement–fixation tests in all cases using 
the serum of patients with known Streptothrix (Actinomycosis) 
patients [40]. Before that, Woodhead, Director of Laboratories at 
the Royal College of Physicians, pointed out that any attempted 
failure to cultivate Streptothrix could easily occur when trying to 
cultivate the well–developed club–shaped form of the organism 
that Fischer repeatedly documented. Woodhead: 
“The first attempt that was at all successful was made by 
Bostrom, who, throwing aside the club-like processes, took for 
his inoculating material the central network, selecting as far as 
possible young growing colonies for his seed material [41].” 
But even Bostrom succeeded in getting only eleven positive 
growths out of several hundred planted [42]. Bolton later 
pointed out that unlike TB, Fischer’s Streptothrix rarely involved 
the central nervous system [43]. Furthermore, although the first 
case of Streptothrix involving the CNS was reported by Ponfick 
[44], Harz never succeeded in cultivating the organism from 
there [45]. Most of this literature was readily available to the 
Alzheimer group.
Moreover, even in the case of using complement–fixation tests to 
detect the far, far more prevalent tuberculosis, Corper reported 
as late as 1916 that such tests were positive in only 30 percent of 
already–proven cases of tuberculosis– whether active or inactive 
[46].
Be that as it may, on November 3, 1906, Alois Alzheimer traveled 
to the auditorium of the Clinic for Psychiatry at the University 
of Tubingen, Germany, to present and describe the pathological 
characteristics of his “unusual” case of dementia. Alzheimer’s 
deceased patient, Auguste Deter, would soon become known as 
the first documented case of Alzheimer’s disease (AD) but not 
right away. At this presentation, Alzheimer also described other 
aspects of Deter’s autopsy, specifically the staining of abnormal 
neurons in her brain:
 M. tuberculosis infects microglia. The microglial cell line 
BV2 (A and B) and primary microglia (C and D), isolated 
from human brain cortex infected with M. tuberculosis 
at an MOI of 2:1 for 6 and 24 h. The arrows indicate 
the uptake of acid-fast bacilli by the microglial cells. 
Scale bars, 20 µm. Note in D the retraction of microglial 
processes after being infected with TB for 24 hours. [From 
Randall PJ, Hsu NJ, Lang D, Cooper S, Sebesho B, Allie N et 
al. Neurons are host cells for Mycobacterium tuberculosis. 
Infect Immun. 2014 May; 82(5):1880-90] with permission.
Figure 6
One of Marinescu's drawings from his Anatomical and 
Clinical Study of the So-Called Senile Plaques, Marinescu 
G. (1912), Encephale (Paris), 1er semestre, pp. 105:32. 
This drawing depicts senile plaque using silver stain with 
an outer layer of fibers that are short and thick with other 
thinner fibers present. Some are almost club-shaped, as in 
the drüsen of Oskar Fischer.
Figure 7
Fischer’s cultivation experiments and complement fixations were 
negative did not rule out the existence of Fischer’s brain microbe.
For example, in the same year that Alzheimer made his 1911 
statement, Harbitz and Grondahl reported repeatedly negative 
Alois Alzheimer (1864–1915) became research assistant to 
Emil Kraepelin at the Munich medical school in 1903.
Figure 8
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“Because these fibrils were stained differently from normal 
neurofibrils, a chemical conversion of the neurofibrils must have 
occurred. This may well explain why the fibrils survived the decay 
of cells” [47]. 
Yes, a chemical conversion. But from what? First there were 
technical considerations concerning the stain used. Key to 
Alzheimer and Oskar Fischer being able to find Alzheimer’s 
pathology was their use of the reduced silver staining technique 
developed by Max Bielschowsky [48,49]. Bielschowsky’s stain 
impregnated silver into nerve fibers using chemicals shared by 
photographers. Bielschowsky believed he had come across a fairly 
reliable way to stain what he was already referring to as abnormal 
“neurofibrils”. Indeed, when both Alzheimer and Fischer used 
the stain, they noticed increased staining in many of the brain’s 
pathological cortical nerve cells. Alzheimer’s assistant, Gaetano 
Perusini, praised Bielschowsky’s method, observing that “by this 
method the plaques are seen impregnated more or less intensely 
with silver nitrate” [50]. By 1911, however, Bielschowsky also 
knew that his stain impregnated more than just neurofibrils– 
findings which drew surprisingly little attention from early 
Alzheimer’s investigators. Many structures, including portions 
of the cerebral blood vessels, under pathologic conditions, could 
stain with his stain. Also Bielschowsky reminded his colleagues 
that when lipid accumulated in diseased nerve cells, neurofibrils 
were entirely pushed to one side by lipid droplets creating an 
area which was entirely free of neurofibrils, but was extremely 
argentophillic– staining well with his silver stain.
Also although silver stains are also known to be very sensitive 
in the staining of bacteria, apparently unknown to Bielschowsky, 
silver nitrate also binds to the outer layers of the tubercle 
bacilli, allowing its visualization as well. By 1911, Von Getegh 
had described a method showing that silver nitrate brought 
tubercular spores into sharp relief. This was followed by the 
findings of Egons Darzins, who later worked at the Robert Koch 
Institute in Berlin, when he recognized that the tubercular bacilli 
could be stained with silver nitrate [51].
Another clue to the “chemical conversion of the neurofibrils” 
that Alzheimer stipulated surfaced in 2004, approximately one 
hundred years after Alzheimer’s presentation in Tubingen. 
German scientists, working mere blocks away from where 
Alzheimer gave his talk, established that the renegade protein 
called “tau” constituting at least in part the chemical conversion 
that Alzheimer was trying to describe could be generated in the 
brains of laboratory animals inoculated with tubercular elements 
[52]. If normal tau protein nourished a neuron’s axon, the 
abnormal “hyperphosphorylated” tau after mycobacterial attack 
formed sticky clumps, much like what happened with Alzheimer’s 
beta–amyloid plaque, resulting in the death of the neuron. 
Tuberculosis itself contains a phosphatide fraction with 3 percent 
phosphorus and has the ability to phosphorylate CNS tissues, 
including neurons [53]. Not only can TB produce the same protein 
phosphorylation [54,55] seen in autopsied Alzheimer’s brains, 
[56] but the very same inflammatory neurotoxic proteinase and 
cytokines instrumental in the creation of beta–amyloid plaque, 
tau aggregation, and neurofibrillary tangles in Alzheimer’s [57] 
are operative and found elevated also in the phosphorylated 
tissue specimens from patients with CNS tuberculosis [53].
As late as 1930, Lubarsch wrote the following:
“It is not emphasized enough that, as it seems, amyloid never 
affects the central nervous system; this fact has already come 
to the attention of Virchow. I, myself, in spite of particular 
circumspection, in cases of most intense generalized amyloidosis, 
have never found even traces of amyloid (in the brain)” [58]. 
How wrong this would prove to be.
Department of Neuropathology, 
Harvard Medical School, Boston, 
Massachusetts, 1909
By 1910 within three years of Alzheimer and Fischer’s initial papers, 
Elmer Ernest Southard, Harvard professor of neuropathology, 
released his own paper on senile and Alzheimer’s presenile 
dementia.
In that paper, Southard put Alzheimer and Fischer on notice that 
with regard to age–related senility, his autopsy of forty–two cases 
of what we now call Alzheimer’s disease showed that the vast 
majority of cases had findings suggestive of tuberculosis– as a rule 
dormant, obsolescent, and acquired earlier in life. Furthermore, 
Southard reported straightforwardly that general tuberculosis 
could “scarcely be excluded with safety from any case” in his 
experience autopsying the age–related dementias [59]. In 
addition, Southard, an expert on the pathology of neurosyphilis, 
found no one–on–one linkage between neurosyphilis in either 
Alzheimer’s or senile dementia [60] (Figure 9).
Kraepelin and Alzheimer’s response to Southard’s work was to 
ignore it. But Southard, regarded as the leading neuropathologist 
in the United States, was difficult to ignore, even for Germany’s 
most ardent psychogenicist and psychiatric classifier-in-chief, 
Emil Kraepelin.
This was not the first time that Southard and Kraepelin had 
crossed swords. And Kraepelin would soon have more than 
enough of Southard, who was a major force behind the eventually 
successful attempt to change Kraepelin’s pet popularization of 
“dementia praecox” back to schizophrenia (Figure 10) [61]. 
Southard was quite blunt and to the point, regarding Kraepelin’s 
championing of the term “dementia praecox.” It meant 
"premature dementia," a chronic yet rapid deterioration of 
thought ability that usually begins in the late teens or early 
adulthood. Though aware that Arnold Pick first used the term in 
1891, Southard was nevertheless irked by Kraepelin’s continued 
attempts to disseminate it. He complained accordingly:
“Perhaps no more unfortunate term than dementia praecox 
has yet been devised for an important group of psychopathic 
patients” [62]. 
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Although E. E. Southard subsequently would become Chairman 
of the Committee on Psychiatry and Neurology for the 
National Research Council, his research focused squarely on 
neuropathological studies—totally uninfluenced by psychiatry. 
Unlike Alzheimer, Southard had no Kraepelin to pay homage to. 
Kraepelin was after a brand–new illness, preferably unknown 
regarding cause for the sake of the financial perpetuation of his 
clinic. Kraepelin knew Southard’s tubercular/dementia reference 
well, made more than familiar to him through the publications of 
still another one of Kraepelin’s rivals, England’s T. S. Clouston. In 
his memoirs, Kraepelin mentions Clouston’s visit to Munich:
“Englishmen rarely came to visit, amongst the more well–known 
colleagues, Clouston came to visit” [63]. 
Office of the Director, Royal Edinburgh 
Asylum, Edinburgh, Scotland, the UK, 
1911
Clouston was “well–known,” indeed. In fact, his fame at that 
time easily rivaled Kraepelin’s. Of the two benchmark events 
chronicled to this day in medicine for 1883, Thomas Clouston’s 
publication of Clinical Lectures on Mental Diseases sits side–by–
side with Emil Kraepelin’s Compendium der Psychiatrie.
Clouston was appointed Lecturer on Mental Diseases at the 
prestigious University of Edinburgh, a post he held in conjunction 
with his position as head of the noteworthy Royal Edinburgh 
Asylum (Figure 11). A celebrated lecturer, Clouston gained 
international notoriety for his explanation of the psychiatric 
disorders of adolescence. Publishing extensively, Clouston began 
with his remarkable Clinical Lectures, followed, later, by his more 
popular Unsoundness of Mind [64]. 
But in far–off Scotland, where he read about Aguste Deter, Sir 
Thomas Clouston could not in any way agree with Alzheimer’s 
thoughts or conclusions. To Clouston, Deter represented neither 
a “new disease” nor what Alzheimer referred to as “a peculiar, 
little–known disease process.” Clouston, a contemporary of 
Alzheimer, would die in 1915 eight months to the day before 
Alzheimer’s death. Clouston wasn’t just a psychiatrist; at the time 
he was superintendent of the prestigious Royal Edinburgh Asylum 
and previous to that, president of the Royal College of Physicians. 
Both Alzheimer and Clouston would soon hold international 
reputations, each considered a pioneer in the treatment of 
mental illness. Yet for the life of him, Sir Thomas Smith Clouston 
thought the case of gaunt, suspicious, hallucinatory, paranoid-
like Auguste Deter an open and shut case of what he often 
referred to in his lectures at Edinburgh University as “monomania 
of suspicion.” Clouston said this:
“This is a good example of those cases of pure monomania of 
suspicion, almost all of whom, according to my statistics, die of 
tuberculosis” [65]. 
Dr. E. E. Southard, MD, Director of Harvard 
Neuropathology.
Figure 9
Emil Kraepelin.Figure 10
Sir Thomas Smith Clouston.Figure 11
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As for the more demented cases such as Deter’s, with her 
incapacitating memory loss, Clouston added this statement:
“This happens in about 30% of cases. It is the event we most 
dread. It is the equivalent to a mental death” [66]. 
So common was the knowledge at Alzheimer’s time that 
tuberculosis (TB), in any form, whether inside or outside of 
the central nervous system, could lead to memory loss–some 
of it severe and progressive–that Clouston was just amazed at 
the exquisite lengths and efforts that Alzheimer and his boss, 
Kraepelin, went to totally ignore it. The fact that central nervous 
system tuberculosis could masquerade as an age–related 
Alzheimer’s dementia with severe memory loss was and still is 
documented to this day [67].
Clouston maintained that since tuberculosis’s psychiatric 
symptoms and dementia appeared long before the disease itself 
advanced to any great degree, many patients committed with 
TB were being sent to asylums instead of special hospitals for 
the treatment of the disease. Carpenter, in a 1903 review in The 
Journal of the American Medical Association, found Clouston’s 
opinions not only justified but “a decisive etiologic (causative) 
factor” in any discussion of a subset of all asylum populations, 
including the one Auguste Deter now found herself in [68]. 
Forbes Winslow of Sussex House Hammersmith, himself a former 
president of the Royal College of Psychiatry prior to Clouston, 
had documented what neurotuberculosis could do to the mind in 
a clear and methodical way. Winslow presented cases of severe 
mental loss at the hands of neurotuberculosis [69]. Among them, 
a gentleman, aged fifty–four who worked as a principal in a fairly 
large school and who died of “softening of the brain,” as his 
tubercular disease choked off vital blood supply to that portion 
of the brain. This man, who was Deter’s age, had admitted at the 
time to his medical attendant that his mind was “gradually fading 
away from him,” yet he carried on, occupying himself with his 
usual workday duties until one day he could not. Winslow said 
this: “Immediately retiring to his own private room, he seated 
himself in a chair, burst into a flood of tears, exclaiming, in wild 
despair, ‘My mind is gone! Altogether gone!’” Ibid., p. 327.
Clouston thought it odd, then, that in 1905, a year before Deter 
died, Paul Claisse and his colleague, Dr. Abrami, presented a case 
to the Medical Society of the Hospitals of Paris, with much the 
same symptomatology of Frau Deter, both psychiatrically and 
neurologically [70]. But in this case, a spinal tap was offered and 
performed, something which Deter’s family was never afforded 
the opportunity of choosing. The spinal fluid drawn from this 
patient showed lymphocytosis (an increase in those white blood 
cells called lymphocytes). And when it was injected into a guinea 
pig, that guinea pig abruptly expired– of tuberculosis. 
Clouston, in a 463–subject autopsy–driven–study, said that 
tubercular patients tended to be demented before death much 
more than the non–tubercular. Furthermore, in the majority of 
cases of dementia, whether presenile or senile, Clouston found 
tuberculosis upon autopsy after death provided it was looked 
for adequately. The only problem was, according to Clouston, 
that nobody, including Kraepelin and Alzheimer and with the 
exception of Southard at Harvard was adequately doing so.
Actually, Thomas Clouston was proving to also be an annoying 
thorn in Emil Kraepelin’s side– on several levels. Clouston 
first coined the term “adolescent insanity” in 1873 for what 
Emil Kraepelin now insisted was dementia praecox. Clouston 
maintained that it was a serious condition from which 30 percent 
of victims wound up with a more serious “secondary dementia.” 
This subset of Clouston’s patients seemed in accord with Bleuler, 
who advanced the theory that Kraepelin’s so–called “dementia 
praecox” of adolescence and certain senile dementias were 
identical.
Clouston knew all about the arbitrariness of Kraepelin’s 
classifications, as well as Kraepelin’s fondness for borrowing the 
terminology and concepts of others. Kraepelin had lifted his entire 
idea for a comprehensive psychiatric classification system directly 
from the writings of fellow German psychiatrist Karl Kahlbaum. 
So when Kraepelin used the term “dementia praecox” for what 
Clouston had already labeled “adolescent or developmental 
insanity” without specifically mentioning Clouston, Clouston felt 
angry, usurped, and slighted:
“Since I first used the term in 1873 and described its general 
characteristics, it has become generally accepted by writers 
in psychiatry. Lately, however, Kraepelin has taken the term 
dementia praecox and applied it to practically my whole group 
of adolescent cases, making it cover the curable and incurable. I 
strongly object…” [66].
Just as annoying, from Kraepelin’s viewpoint, was Clouston’s 
finding that most of the people who died of tuberculosis in 
mental institutions were demented and that Clouston’s third 
stage of tubercular dementia in effect mirrored the symptoms of 
end–stage Alzheimer’s, leading to “the abolition of mind in all its 
forms, of senile dementia” [64]. 
To Emil Kraepelin, this was a high–stakes conflict, and Kraepelin 
knew that very well. If there was a direct infectious continuum 
involving the evolution of dementia praecox/schizophrenia to 
Alzheimer’s presenile dementia and then on to senile dementia 
itself, then two of Kraepelin’s cherished categories praecox 
and Alzheimer’s disease were in jeopardy. Indeed the term 
“Alzheimer’s disease” would be superfluous a mere pit stop 
as dementia praecox evolved in some people toward senile 
dementia. 
Anatomie Laboratorium, Nervenklinik, 
Department of Clinical Psychiatry, 
University of Munich, Germany, 1910
Showing all the assurance of a favored son, Alzheimer’s young 
workhorse, Gaetano Perusini, proceeded to autopsy the four 
cases Alzheimer assigned to him, the first of which was the brain 
of Auguste Deter. Perusini was bright. Perusini was intuitive. 
In addition, Perusini spoke fluent German. But Perusini was 
also rather young and clinically unseasoned, having graduated 
from the School of Medicine of the Catholic University in Rome 
and then having specialized mainly in the “endemic cretinism” 
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prevalent in northern Italy — Tabes Dorsalis of syphilitic origin, 
and Friedreich’s condition [71]. He would work in Alzheimer’s 
laboratory until 1912 and die within three years of his departure, 
a young life cut short while trying to save a fellow soldier during 
World War 1 (Figure 12). 
When Alzheimer published the fourth volume of his book 
emphasizing abnormal tissue in the cerebral cortex of brains 
with mental disease, one of its chapters was titled “The Perusini 
Cases.” Perusini helped Alzheimer define Alzheimer’s disease 
so much that some, to this day, call it “la malattia di Alzheimer–
Perusini”…the disease of Alzheimer–Perusini [72].
One of the Alzheimer’s autopsies Perusini performed was on 
a syphilitic. But that patient also had apical lung scarring from 
pulmonary tuberculosis. The other three patients assigned to him 
did not have syphilis. Perusini knew that with regard to syphilis 
being behind Alzheimer’s disease that Alzheimer, as well as Oskar 
Fischer of Prague, never gave even a hint or implication that 
syphilis was exclusively or largely behind Alzheimer’s. Perusini 
indicated that in syphilis, “the brain usually lacks the described 
plaques and ganglion cell alterations” yet it was in this case of 
syphilis along with lung scarring from a previous tubercular attack 
that Perusini saw just such plaques and tangles. Perusini called 
the tubercular lung lesion “old” yet simultaneously left the door 
open in general to an “old” cause for his Alzheimer’s patients. He 
noted that: 
“All observations in the cerebral cortex (including plaques and 
tangles) and particularly in the glia indicate with certainty that 
we are dealing with an old pathological process that advances 
over the course of years” [50].
Simchowicz was first to use the term “senile plaque.” The 
term “plaque,” however, has not historically been reserved for 
either Alzheimer’s disease or senile dementia. As far back as 
1830, Papavoine [73] described the tubercles of tuberculosis as 
“plaques” and granulations in the brain’s pia mater, the very area 
that Perusini now saw major Alzheimer’s alterations in (Figures 
13).
Papavoine was not the first to study the pia with regard to 
tuberculosis. Previously, Rindfleisch closely followed the histology 
of miliary tubercles in the pia, finding the larger arteries to be the 
seat of unilateral swelling, while the smaller arteries presented 
spindle–shaped thickenings all originating in the adventitia of 
blood vessels [74].  Figure 14. Fischer described similar spindle-
shaped thickenings of nerve fibers terminating with club forms 
in plaques.
To Barlow, such infiltration of the pia with cerebral tuberculosis 
could also lead to the classic Alzheimer’s degeneration reported 
by Fischer and Alzheimer of both the central mass of nerve 
fibers (axis–cylinders) and ganglion cells leading, at times, to 
neurofibrillary tangles [16]. By 1915, Sir William Osler spoke of 
the “plaque” of focal tuberculous meningoencephalitis, usually 
situated on the surface of one of the cerebral hemispheres and 
less often elsewhere [75]. Although of meningeal origin, Osler 
said, the involvement of cortical tissue from such tubercular 
plaque was inevitable.
Gaetano Perusini continued to summarize his Alzheimer’s 
findings:
Gaetano Perusini, 1910.Figure 12
The pia mater, or “pia,” which is the innermost of the 
three coverings of the brain called the “meninges.” 
The pia mater, as shown above, firmly adheres to 
the surface of the brain and spinal cord. It is a very 
thin membrane but highly vascular and filled with 
small blood vessels.
Figure 13
The layers of an artery. Its adventitia is on the 
outside, the external coating of a blood vessel. 
The adventia is a tough layer consisting mainly of 
collagen fibers that act supportively. Perusini found 
thickening of the Alzheimer’s adventia.
Figure 14
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“A further common finding in all three cases (that were 
not syphilitic) concerning the blood vessels is the thickened 
appearance of the adventitia, earlier described. This adventitial 
enlargement was common to both small and large blood vessels 
of the brain: at times, presented as quite strange thickenings, 
occasionally only involving one side of the blood vessel. At times 
this gave a half moon appearance in the Van Gieson preparation 
while in others, the blood vessel sometimes appears as a thick 
lumen-less (closed) red ring so that it could be confused with 
amyloid bodies…” [50].
Approximately two and a half decades before this, Guarneri 
studied the histological changes in twelve cases of tuberculous 
meningitis, seeing similar thickened adventitia, with the same 
strange semilunar half–moon thickenings that Perusini mentions, 
occasionally involving one side of the blood vessel [76]. And 
fourteen years before Perusini, Hektoen, in the Rockefeller 
Journal of Experimental Pathology, saw similar vascular changes 
in cerebral tuberculosis “in the form of a homogeneous ring which 
stains…bright red with Van Gieson’s stain” and with particular 
thickening, once again, of the adventitia [77].
So according to Hektoen, Perusini’s findings of thickening of 
the Alzheimer’s adventia simulate what happens when tubercle 
bacilli, carried by the blood, are localized in the arterial adventitia. 
In fact, “In cerebral arteries only the adventitia is usually 
involved,” Hektoen wrote. He added, “All authors emphasize the 
prominent part played by the adventitia in the formation of the 
tubercles and more diffuse infiltrations in tuberculous meningitis 
[77]. This, Hektoen said, was because it was in the lymph spaces 
in this adventitial layer of the arterial wall that the tubercle bacilli 
appeared to find the most favorable conditions for rapid growth.
Perusini’s summary of tissue changes generally found in 
Alzheimer’s continued to mirror Hektoen’s findings on tubercular 
changes involving the brain. When Perusini talked about the 
ability of Alzheimer’s to make changes in the intima of pial arteries 
as well as the arterial adventitia, Hektoen made this statement:
“The general conclusion is consequently warranted that in 
tuberculous meningitis of bloodborne infection an unexpectedly 
frequent and significant localization of the bacilli occurs upon the 
intima of pial arteries in addition to that in the arterial adventitia” 
[77]. 
Perusini also noted that plaque and tangle formation in all four of 
his cases of Alzheimer’s were limited to the cerebral cortex, even 
in the one case with severe spinal–cord involvement. Hektoen 
observed that tuberculosis, with time, also preferred to attack 
the cerebral cortex.
Just months earlier, Perusini saw Kraepelin shaken when the 
American professor, Southard, now at Harvard, published 
autopsy–based linkage of active or dormant TB to Alzheimer’s. 
By all indications, E. E. Southard was one of the most remarkable 
physicians in early twentieth–century medicine. In fact, Southard 
had reported that general systemic tuberculosis could “scarcely 
be excluded with safety from any case” of age–related dementia 
or Alzheimer’s disease [59].
The single worst disease present in European cities was 
tuberculosis, and even by 1800, it was understood that no other 
disease was as common or as deadly. Yet Perusini knew that 
Alzheimer and Kraepelin both paid little attention to the one 
disease except for syphilis that could possibly account for the 
sudden rise in age–related dementias. 
Office of Medical Research Director, 
the State Institute for Geriatrics, 
Warren, Pennsylvania, 1972 
As he read Oskar Fischer’s turn-of–the–century study in the 
1970s, nothing, including Fischer’s referencing a tubercle, and the 
“miliary” tubercular–like distribution of Alzheimer’s brain plaque, 
seemed out of order to Pennsylvania neuropathologist Philipp 
Schwartz (Figure 15). Nor could he find any fault in Southard’s 
Alzheimer’s autopsy conclusions at Harvard or Clouston’s original 
research implying Alzheimer and the senile dementias as being a 
result of old and mostly dormant foci of TB. Rather, Schwartz’s 
findings were comparable. Schwartz made this observation:
“Chronic infections, and particularly tuberculosis, have 
heretofore been regarded as the most frequent and therefore 
the most important cause of systemic amyloid degeneration. 
This fact induced us to look for sequels of pulmonary tuberculosis 
in around 150 cases of senile and presenile (Alzheimer’s) 
amyloidosis. Postmortem roentgen photography, as well as 
careful macroscopic and histologic examination of the lungs, 
disclosed typical calcifications of healed intra-pulmonary or 
lymphoglandular tuberculous infiltrates in almost every instance of 
this series, and quite often typical cicatrices of old lymphonodular 
bronchial lesions. Doubtless, the great majority of our senile and 
presenile patients displaying cerebral amyloidosis, suffered from 
pulmonary tuberculosis sometimes before symptoms of senile 
deterioration arose” [78]. 
Originally a Swiss pathologist, Schwartz, a student of Löeffler, 
having completed his work in Ankara, moved to the United 
States to become Director of Research at the Pennsylvania 
Professor Dr. Med. Philipp Schwartz American 
Medical Association Award USA, 1960.
Figure 15
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State Institute in Warren. There, through extensive human and 
animal autopsy–driven studies, Schwartz almost invariably found 
tubercular foci in Alzheimer’s bodies usually latent. Though 
seemingly dormant, he knew that such foci could reactivate at 
any time, leading through either immunologic mechanisms or 
direct systemic invasion to tissue changes identical to those seen 
by Fischer and Alzheimer [78,79]. It is unclear why the elites 
of American medicine shelved Schwartz’s extensive and well-
documented neuropathological work on Alzheimer’s, other than 
the fact that it brought up a topic both out of their comfort zone 
and interest– a wider role for cerebral tuberculosis.
One of the main reasons why Dr. Philip Schwartz could go where 
few had gone before him was his introduction of a critical method, 
still used today, whereby the flourochrome dye Thioflavin–S lit up 
amyloid deposits, both in humans and animals. Using this process, 
Schwartz proceeded to fashion the textbook Amyloidosis: Cause 
and Manifestation of Senile Deterioration which stands as a 
monument to the course that solid basic research on Alzheimer’s 
and the amyloid neurodegenerative disorders could have taken.
Neurosyphilis had diminished to a point of rarity, and Schwartz 
saw amyloidosis both “primary” (supposedly noninfectious) 
and secondary (infectious) in the brain and elsewhere, mostly 
as the by–product of underlying infectious tuberculosis, usually 
dormant. Such infection could then, with time or age, either 
reactivate itself or be reactivated by a host of traumatic, chemical, 
biologic, or physical insults. He had autopsied hundreds of cases. 
In each case, animal or human, he documented plaque in the 
brain, accompanied by the amyloid degeneration of nerve fibrils 
as a result of systemic infection.
Schwartz injected M. tuberculosis into the peritoneal sac of 
twenty–two guinea pigs, all of whom died within twenty–eight to 
ninety–six days [79]. All but four exhibited amyloidosis. Yet only 
one of his control animals came down with amyloidosis. With his 
guinea pig experiment, Schwartz supported the findings of Hass, 
who in a large series of rabbits found that three out of every 
four animals developed amyloidosis within fifteen days of being 
infected with bovine tuberculosis. Furthermore, the injection of 
tuberculin into Haas’s animals only hastened the development of 
amyloidosis [80].
In his multipart amyloid study for the Archives of Pathology, Hass 
and his colleagues made this conclusion:
“In the present investigation, the only infectious disease which 
served as an apparent cause of amyloidosis was tuberculosis" (80 
p. 228). 
All twenty-one of Hass’s human subjects with amyloid disease 
had chronic pulmonary tuberculosis due to the human tubercle 
bacillus.
Conclusion
Throughout Alois Alzheimer’s papers, it is both remarkable and 
frankly inexplicable that despite the available, huge amount 
of peer studies done on tubercular attack on the brain and the 
nervous system degenerative or otherwise– Alzheimer never 
considered this disease in any of the differential diagnoses found 
in his many publications. Thus, although Neurologist/psychiatrist/
pathologist Alois Alzheimer was technically excellent in his 
neuropathological presentations, his laboratory preparations, 
and their assessment, he seemed lacking in his differential 
diagnosis. But, then again, even scientific icons can be mistaken.
By late 1912, Alzheimer, who had been appointed as the Chair 
of Psychiatry at the University of Breslau, took on the case of a 
twenty-seven-year-old woman of slow speech and weakness who 
experienced frequent vomiting [81]. Soon afterward, this patient 
experienced a noticeable stiffness in her gait, with accompanying 
weakness and sharp, intermittent, spasmodic pains in her left 
arm, which had increased in intensity. Alzheimer noted that she 
was depressed, often crying, which, in turn, sometimes resulted 
in convulsions. She was first sent to a tuberculosis sanatorium 
and then released to Dr. Ludwig Mann’s private office. From 
there, and for questionable reasons, she found her way into 
a psychiatric clinic for a consult with Dr. Alzheimer, although 
Alzheimer admitted that she seemed completely rational and 
oriented when she was seen. In December 1911, her father died, 
and she was understandably shocked by the event. Yet Alzheimer 
made no attempt to chart the cause of her father’s death.
So we have a young person, seriously physically sick, sent for 
a psychiatric evaluation. This in itself could go a long way in 
explaining her depression and crying. She was seeking a cure 
for a physical illness, and that cure seemed unreachable. After 
treatment in the TB sanatorium, she mentioned that there was 
temporary improvement, but it did not last long; her disease 
returned with a vengeance. Alzheimer also charted that when 
she swallowed, it was often the wrong way, and apparently food 
got “up her nose,” a sign that Alzheimer realized showed possible 
bulbar involvement. But there was also the possibility of spinal 
involvement, causing what Alzheimer noted as “painful spastic 
convulsive states of extremities.” The term “bulbar” means of or 
relating to a bulb, specifically involving the medulla oblongata, 
often called simply the medulla. The spine sits just below the 
medulla.
As for this patient’s frequent vomiting, the medulla houses the 
chemoreceptor trigger zone (CTZ), which communicates with 
other structures in the vomiting center to initiate vomiting. The 
word “bulbar” can also refer to the nerves and tracts connected 
to the medulla, important in proper swallowing.
Alzheimer’s write–up of this patient, posthumously edited 
and published by Spielmeyer, was titled with reference to 
the symptoms: “On a Peculiar Disease of the Central Nervous 
System with Bulbar Symptoms and Painful Spastic Cramps of the 
Extremities.” It appeared in Zeitschrift fur die Gesamte Neurologie 
und Psychiatrie. The word “peculiar” in this title is reminiscent of 
its similar use by Alzheimer for Deter’s Alzheimer’s disease:
“All in all we have to face a peculiar disease process. Such peculiar 
disease processes have been verified recently in considerable 
numbers” [82]. 
But how “peculiar” was either case?
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This twenty–seven–year old governess was originally admitted 
to a TB sanatorium. Alzheimer knew his patient was running 
symptoms of bulbar palsy, which can include progressive difficulty 
with chewing, talking, and swallowing. Yet eight years before 
Alzheimer saw this patient, in 1905, Dr. D. J. McCarthy of Phipps 
Institute at Johns Hopkins described a similar case of bulbar palsy 
from cerebral tuberculosis, also with difficulty of swallowing, the 
same brief remission, the same weakness of the arms and legs, 
and the same fatal termination that Alzheimer’s patient would 
soon experience. Accompanying this, mentioned McCarthy, “Not 
a cell in the spinal cord was in a normal healthy condition” [83]. 
It has long been known that severe tuberculous meningitis can, 
in certain cases, produce the same bulbar palsy that Alzheimer’s 
patient had, either through blood–borne seeding or extension 
from the base of the brain downward to the medulla on its path 
to the spine [84].
The medulla is continuous with the spinal cord, which explains 
Alzheimer’s patients’ spinally related “painful spastic convulsive 
states of the extremities”.
What is surprising is that this and other cases of CNS spinal 
involvement with or without TB meningitis were extraordinarily 
and widely documented in the literature both prior to and during 
Alzheimer’s time. Kelynack, a UK neurologist, mentioned in 1908 
just five years before Alzheimer saw his patient that when cerebral 
tuberculosis affects the spinal membranes, symptoms in the 
cervical region could include violent painful contractions in the 
arm, forearm, and shoulders, usually accompanied by weakness 
[85]. And lower down, in the lumbar spine region, inflammation 
from the disease could yield similar painful convulsions and 
weakness of the lower extremities, creating a stiffness of gait.
By all indications, this young woman was seriously sick and 
suffering from a systemic/neurological disease with general as 
well as neurologic symptoms. Yet when Alzheimer turned the 
case over for presentation to the Breslau Psychiatric–Neurologic 
Union in February of 1913, he weighed in with the awkward, 
if not reckless, conclusion that this young lady was suffering 
from a hysterical condition of the mind, as first popularized by 
Sigmund Freud. Alzheimer noted, “An organic disease (such as 
neurotuberculosis) is unimaginable. Clinical observation points 
to a strong psychogenic (originating in the mind) suggestibility” 
[47].
She simply was, then, according to Alzheimer, an open and shut 
case of psychiatric hysteria.
Dr. Ludwig Mann, extremely familiar with the case, did not 
agree. To Mann there was no question that the patient had 
chronic central nervous system disease, and he considered the 
hysterical symptoms a mere by–product of such disease. Mann 
could not have been more correct. Within four months of that 
presentation, this twenty–seven–year–old had seizures, ran 
a temperature of 41.8 degrees Celsius (107.24 Fahrenheit), 
became almost entirely unresponsive, and died. Obviously, then, 
this was a case of more than psychiatric hysteria, and it was time 
for some damage control. Alzheimer, after the girl’s death, made 
this statement:
“Even if there could now be no doubt that an organic condition 
lay at the basis of the clinical picture (which there was no longer 
any doubt), it still appeared quite impossible to classify it with any 
known illness” [47].
Alzheimer’s use of the term “impossible to classify it with any 
known illness” again sounds like his impression of Auguste Deter 
with her “Alzheimer’s disease.” Yet, at least in the case of the 
deceased twenty–seven–year–old, this statement proves to be 
presumptive. In the meantime, no serious effort, as with Deter, 
was exerted to perform a spinal tap or other diagnostics to rule 
out tubercular or other infectious disease.
Alzheimer then admitted what should have been his opening 
assessment to begin with:
“Our anatomic and physiological knowledge (of this case of the 
twenty–seven–year old) is burdened with countless gaps, which 
can for this reason easily lead us to erroneous conclusions” [47]. 
Such as jumping to the conclusion that this case was one of 
hysteria.
Yet when left with the grizzly task of autopsying this girl, 
Alzheimer’s findings show serious pathology entirely unrelated to 
a mental condition. At one point, Alzheimer considered Wilson’s 
disease (hepatolenticular degeneration) in his differential 
diagnosis. Wilson’s disease is thought to be a genetic, copper-
hoarding disease, but it should also be noted that acid-fast forms 
can cause chromosomal damage and genetic changes [86].
Although Alzheimer was unable to isolate any organisms during 
an autopsy from his patient, the stains he used and which 
microbes he was looking for were not clearly listed. Yet it was 
in Wilson’s disease that Dr. Virginia Livingston and Dr. Eleanor 
Alexander–Jackson later would isolate acid–fast mycobacterial, 
tubercular–like microorganisms. Traditionally, since Koch (1882), 
mycobacteria such as tuberculosis and leprosy were identified by 
their capacity to retain certain red dyes such as carbol-fuschsin 
after being rinsed with acid alcohol, a common laboratory 
reagent. These microorganisms were and still are therefore 
called “acid-fast”.
One of Livingston’s cases of Wilson’s disease involved a thirty–
four–year–old woman. Livingston and Jackson found intracellular 
acid-fast microorganisms in mice and guinea pigs after injecting 
them with the bacteria isolated from this woman’s blood. 
These animals then developed the same chronic disease of 
the liver, spleen, and brain that Livingston’s patient had [87]. 
It is practically medical dictum that any Parkinson’s patient 
under forty should be carefully checked for Wilson’s disease 
[88]. A similar microorganism was cultured from the blood of 
meningoencephalitis patients by C. G. Burn at the Rockefeller 
Institute Hospital in New York [89]. But when, in 1970, Livingston 
and Jackson revisited Burns bacillus, they determined that it, too, 
stained “acid–fast” Figure 16 [90]. 
Schömberg, like Breslau, is a town in Silesia, a spa town in the 
north of the Black Forest in Baden–Württemberg. Breslau sat 
only fifty–one miles west by southwest of where Alzheimer’s 
Breslau clinic was. By 1911, Dr. Bruno Bandelier, medical director 
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A small fraction of the literature directly pertinent to the signs and symptoms of the twenty–seven–year old governess’s case—
readily available to Dr. Alzheimer. Such citations regard tubercular involvement of the brain and spinal column. An exponentially 
greater number of references were in existence at that time.
Figure 16
of Schömberg’s Schwarswaldheim TB sanatorium, published A 
Clinical System of Tuberculosis Describing All Forms of the Disease 
[91]. The book, quickly picked up by William Wood and Company 
in New York, was also readily available to Alois Alzheimer in its 
original German version by 1911 a year and a half before he saw 
the ill-fated twenty-seven-year-old governess.
Bandelier wrote with physician Otto Roepke, at the time director 
of another German TB sanatorium at Stadwald in Melsungen, near 
Cassel. It is doubtful whether Alzheimer ever reviewed Bandelier 
and Roepke’s Die Klinik Der Tuberkulose or the hundreds and 
hundreds of well–documented references behind it, but by May 
1912, obviously many in the German medical profession had. It 
required a second edition after only a year and a half and had 
become a virtual necessity for the medical profession. Its goal: to 
stimulate further interest in the clinical and practical recognition 
and treatment of the disease.
Bandelier and Roepke’s English version was cited in the March 
13, 1913, issue of Nature right along with Professors Alzheimer 
and Nissl’s Histological and Histopathological Work over the 
Cerebral Cortex [92,93]. That Roepke and Bandelier would 
question Alzheimer’s differential diagnosis in the case of the 
twenty–seven–year–old governess was a given. Besides the 
multitude of individual signs and symptoms Alzheimer listed that 
were compatible with tuberculosis of the nervous system, the 
authors had made this caution:
“Hysteria and tuberculosis approach each other closely. Even 
a slight tubercular infection, and still more fever, anemia, 
and inanition may in latent hysteria call forth such severe 
manifestations that the symptoms of tuberculosis may be masked 
by those of hysteria; such a condition has been called “hysterical 
tuberculosis” [92].
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In no way could Otto Roepke agree with Alzheimer’s diagnosis 
of the twenty–seven–year–old. Alzheimer’s charting of 
“weakness” could quite conceivably have been from an anemia 
of a chronic disease such as tuberculosis, while inanition–lack of 
mental or spiritual vigor and enthusiasm–often comes across as 
depression. The symptom of “painful spastic convulsive states 
of the extremities” speaks for a spinal–cord involvement or 
compression from the disease, whereas the bulbar symptoms 
speak of involvement of the medulla.
Alzheimer died at only fifty–one, for reasons to this day not 
certain, but no one at any time has ever said that being a 
pathologist or neuropathologist was the safest of occupations. 
Historians report that Alzheimer’s encounter with death began 
with a severe cold with flu–like symptoms, but that infectious 
endocarditis was responsible for his death.
As early as 1911, Bruno Bandelair and Otto Roepke published their 
book, in German, in which all of the postmortem explanations 
for Alzheimer’s early death (“infectious angina,” infectious 
endocarditis, nephritic kidney disease, and inflammatory disease 
of the joints) could be found to spring forth under the umbrella 
of blood–borne tuberculosis. So the question presents, could 
Alzheimer have been one of the seven million people worldwide 
whom TB killed each year at that time?
Infectious endocarditis is no stranger to systemic tuberculosis, 
as B. C. Millar points out [94]. But even before that, TB, a 
disease capable of infecting every organ in the body the 
heart no exception was first reported to cause a tubercular 
endocarditis (TBE) in 1892, and many other cases since [95]. 
British pathologist/researcher William Stark, explained how, 
after a flulike lung involvement, TB could and was carried by the 
bloodstream to various parts of the body, including the heart, 
the kidney, the joints, and the brain. It could then either turn into 
progressive disease or reactivate, even decades later. These were 
the “little lumps” that Stark uncovered on autopsy after autopsy. 
Pathologist Stark died at age thirty. Stark thus anticipated the 
tubercular findings of the famed Laennec, a contemporary of 
Parkinson. But after his death, Stark’s words fell on deaf ears, 
only to become a curious controversy among students in various 
countries throughout Europe. Among these students was Bichat 
(1771–1882), a French pathologist who had autopsied countless 
tuberculous patients before he died of the disease at thirty–one, 
uttering as follows:
“Not much is really known about the pathology of phthisis 
(tuberculosis), for few autopsies have been done because of the 
foolish fear among physicians that the disease is catching” [96].
Both his own untimely death and the findings of Robert Koch 
would soon prove him wrong.
Just before Bichat died, seasoned pathologist Gaspard Laurent 
Bayle, also from France, predicted that tuberculosis was an 
infectious disease before this was proven. He was also first 
to describe the millet–like seed bodies as “tubercles.” Bayle 
himself died at the age of forty–two. But it was Bayle’s junior 
collaborator, René Laënnec, whom Parkinson personally knew, 
who would indelibly stamp on the Western mind that not only 
was tuberculosis infectious, but that it could literally attack every 
tissue of the human body. Laënnec did hundreds of postmortem 
examinations of persons who had died of tuberculosis; he died at 
the age of forty-five.
Not all that much time had elapsed since Alzheimer’s discovery 
of Alzheimer’s disease when Neurologist I. J. Sands gave his talk 
on senile and presenile psychoses for a 1918 clinical conference 
at Columbia’s Department of Neurology in New York City [97].
After a review of the age–related dementia literature, including 
that of Alzheimer and Fischer, Sands got around to his own 
work. Using Alzheimer’s own descriptions of the tangles, plaque, 
and clinical progressive memory loss for a man in his forties, 
Sands matched Alzheimer with a case that he mentions typified 
Alzheimer’s cases.
Sands first saw this patient, E. K., in late September 1917, and 
this patient died about a month afterward, three months after 
admission. Autopsy showed many of the changes typifying 
Alzheimer’s age–related dementia, including a brain very much 
smaller than normal, definite temporal lobe atrophy, dilated 
ventricles, and an atrophic cortex. Microscopic findings included 
a somewhat thickened pia and a definite loss of cells in the first 
three layers of the cortex. There also was an increase in neuroglia, 
the presence of senile plaque, and whorls and the snarls of classic 
tangles.
But there was more. Just across from the bronchopneumonia, on 
the top of the right lung sat an area of tubercular involvement. 
And although Sands, relying on gross findings at autopsy, never 
did the exhaustive, painstaking slices and stains needed to 
rule out tubercular central–nervous–system involvement, he 
nevertheless realized that the disease had spread from the lungs 
through the blood to other organs because this patient’s liver 
and spleen were also riddled with miliary TB. A gross autopsy 
nevertheless showed marked atrophy of the cerebrum, the 
beginning of plaque formation, and neurofibrillary changes. So 
Sands completed his summary of findings as marked cerebral 
atrophy, with plaques and tangles of the Alzheimer’s type 
alongside chronic pulmonary tuberculosis of the lungs, liver, 
and spleen- a scenario not unlike what Southard, Schwartz, and 
Clouston repeatedly had reported.
By 2013 Mawanda and Wallace’s “Can Infections Cause 
Alzheimer’s Disease” struck down some of the commonly 
entertained pathogens for AD such as herpes simplex virus type 
1, Chlamydia pneumoniae, and several types of spirochetes. 
Instead they pointed to two prime suspects for Alzheimer’s 
amyloid-beta deposition: “especially chronic infections like 
tuberculosis and leprosy” [2]. 
Mawanda and Wallace’s summation was correct, with the 
understanding that leprosy could not be behind Alzheimer’s 
disease. This leaves us with but a single choice backed up by this 
historical review. And that choice is tuberculosis, its allied germs 
and moreover it’s ever present and preferred cell-wall-deficient 
(CWD) configurations.
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